RESUMO
In the experiment on rats it was shown that injection of somatotropin (1 ED/kg, i.m. at 1, 3, 5, 7 and 9 days) after combined irradiation and mechanical injury (4.5 Gy, LD50/30 and plural fractures) improved the overall condition of the rats and increased the survival. The drug accelerated the bone regeneration.
Assuntos
Osso e Ossos/lesões , Osso e Ossos/efeitos da radiação , Hormônio do Crescimento/administração & dosagem , Articulações/lesões , Articulações/efeitos da radiação , Lesões Experimentais por Radiação/tratamento farmacológico , Animais , Injeções Intramusculares , Masculino , RatosAssuntos
Poluentes Ocupacionais do Ar/toxicidade , Indústria Química , Animais , Feminino , Cobaias , Lubrificação , Masculino , Gravidez , Ratos , U.R.S.S.RESUMO
Dimebone was shown to inhibit monoamine oxidase (MAO) deaminating dopamine and serotonin, decrease dopamine metabolism in the basal ganglia of the rat brain, increase noradrenaline level and depress dopamine deamination in the hypothalamus. Dimebone first increased and then diminished the release of dopamine in the cortex, with the concomitant MAO activation and the increase in dopamine and noradrenaline levels. The in vitro experiments have demonstrated that dimebone (10(-4)) preferentially inhibited MAO activity, type B and dopamine deamination in homogenates of different rat brain structures. The role of MAO inhibition in the mechanism of dimebone action on the catecholamine metabolism in the brain structures and its stimulating effect on CNS are discussed.
Assuntos
Encéfalo/metabolismo , Antagonistas dos Receptores Histamínicos H1/farmacologia , Indóis/farmacologia , Inibidores da Monoaminoxidase , Animais , Gânglios da Base/enzimologia , Encéfalo/enzimologia , Masculino , Atividade Motora/efeitos dos fármacos , RatosAssuntos
Células APUD/efeitos dos fármacos , Indóis/farmacologia , Células APUD/metabolismo , Animais , Anti-Hipertensivos/farmacologia , Anti-Hipertensivos/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Cães , Células Enterocromafins/efeitos dos fármacos , Cobaias , Hipertensão/tratamento farmacológico , Indóis/uso terapêutico , Coelhos , Ratos , Relação Estrutura-AtividadeRESUMO
It was reported previously that the analogues of dimecabin (1,2-dimethyl-3-carbethoxy-5-oxyindole),2-methyl-3-carbethoxy-5-oxyindole and the derivatives of 2-methyl-3-carbethoxy-4, 5, 6, 7-tetrahydroindole substituted in the 1st position reduce the content of argentaffinic substance in enterochromaffin cells (EC) for a long period of time. It has been shown that "recognizability" of the acetyl derivatives of 4, 5, 6, 7-tetrahydroindole by the EC receptor systems is preserved. Administration of the acetyl derivatives into the stomach (10 mg/kg for 5 days) induce a prolonged decrease in the argentaffin substance content in EC, and augment the noradrenaline level without exerting a pronounced effect on the dopamine content. These substances also inhibit monoamine oxidase and acetylcholinesterase activity in the rat brain. Detection in EC of the biologically active substances common to the APUD-system and the brain suggests a new trend in the study into the action mode of indole compounds.